Ginkgo Bioworks
Boston · Founded 2008
About Ginkgo Bioworks
Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $1.6B
- Funding stage: IPO
- Last round: Grant (Apr 2024)
- Ticker: nyse:DNA
- Website: ginkgobioworks.com
- Phone: +1 877 422 5362
Industries & Categories
Biopharma, Biotechnology, Chemical
Social Profiles
Canonical: https://fsome.com/organization/ginkgo-bioworks-102752 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.